SE8601644L - Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning - Google Patents

Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Info

Publication number
SE8601644L
SE8601644L SE8601644A SE8601644A SE8601644L SE 8601644 L SE8601644 L SE 8601644L SE 8601644 A SE8601644 A SE 8601644A SE 8601644 A SE8601644 A SE 8601644A SE 8601644 L SE8601644 L SE 8601644L
Authority
SE
Sweden
Prior art keywords
human
antibodies
region
antibody preparation
determinants
Prior art date
Application number
SE8601644A
Other languages
Unknown language ( )
English (en)
Other versions
SE8601644D0 (sv
SE452065B (sv
Inventor
Ulf R Nilsson
Karl-Erik Svensson
Bo Nilsson
Original Assignee
Ulf R Nilsson
Svensson Karl Erik
Bo Nilsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf R Nilsson, Svensson Karl Erik, Bo Nilsson filed Critical Ulf R Nilsson
Priority to SE8601644A priority Critical patent/SE452065B/sv
Publication of SE8601644D0 publication Critical patent/SE8601644D0/sv
Priority to PCT/SE1987/000142 priority patent/WO1987006344A1/en
Priority to AU72868/87A priority patent/AU7286887A/en
Priority to EP19870902799 priority patent/EP0263161A1/en
Priority to JP50252087A priority patent/JPS63503089A/ja
Publication of SE8601644L publication Critical patent/SE8601644L/sv
Publication of SE452065B publication Critical patent/SE452065B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8601644A 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning SE452065B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
PCT/SE1987/000142 WO1987006344A1 (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
AU72868/87A AU7286887A (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
EP19870902799 EP0263161A1 (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
JP50252087A JPS63503089A (ja) 1986-04-11 1987-03-19 ヒトｃ３中のある抗原決定基に対する抗体調製物及びその使用並びにその生産

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Publications (3)

Publication Number Publication Date
SE8601644D0 SE8601644D0 (sv) 1986-04-11
SE8601644L true SE8601644L (sv) 1987-10-12
SE452065B SE452065B (sv) 1987-11-09

Family

ID=20364149

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Country Status (5)

Country Link
EP (1) EP0263161A1 (sv)
JP (1) JPS63503089A (sv)
AU (1) AU7286887A (sv)
SE (1) SE452065B (sv)
WO (1) WO1987006344A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572856B1 (en) 1998-09-10 2003-06-03 The University Of Virginia Patent Foundation Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
CA2328356A1 (en) * 1999-12-22 2001-06-22 Itty Atcravi Recreational vehicles
JP2003522159A (ja) * 2000-02-08 2003-07-22 ザ ユニバーシティ オブ ヴァージニア パテント ファウンデーション 抗Ｃ３ｂ（ｉ）抗体を用いる感染の予防および治療のための方法
US20040224423A1 (en) * 2001-04-30 2004-11-11 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons
US6617308B2 (en) * 2001-04-30 2003-09-09 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
US7294688B2 (en) * 2001-04-30 2007-11-13 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
US7049397B2 (en) * 2001-04-30 2006-05-23 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
US7314717B2 (en) 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US20020160434A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons
US6602855B2 (en) * 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
US6756476B2 (en) 2001-04-30 2004-06-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
US6593298B2 (en) 2001-04-30 2003-07-15 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
US20020160532A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
AR069130A1 (es) * 2007-11-02 2009-12-30 Novartis Ag Moleculas de enlace de la opsonina principal del complemento (c3b) y metodos para modular el componente de complemento
US20100291106A1 (en) * 2009-05-06 2010-11-18 Novartis Ag Compositions and methods for antibodies targeting complement protein c3b
EP2553465A4 (en) * 2010-03-31 2013-10-23 Anamar Ab METHOD FOR DETECTING INFLAMMATION TISSUE DEGRADATION
JP5859557B2 (ja) * 2010-11-02 2016-02-10 カイファ， インコーポレイテッド 補体活性化についての側方流動イムノアッセイおよび補体関連障害のポイント・オブ・ケア評価のための使用法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
GB2117514B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Polyvalent antiglobulin reagent
US4642284A (en) * 1983-06-13 1987-02-10 Scripps Clinic And Research Foundation Method and system for detection of complement pathway activation

Also Published As

Publication number Publication date
JPS63503089A (ja) 1988-11-10
WO1987006344A1 (en) 1987-10-22
SE8601644D0 (sv) 1986-04-11
EP0263161A1 (en) 1988-04-13
AU7286887A (en) 1987-11-09
SE452065B (sv) 1987-11-09

Similar Documents

Publication Publication Date Title
SE8601644L (sv) Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
EP0597829A4 (en) NEW MONOCLONAL ANTIBODY DRESSES AGAINST A NEW ANTIGEN ASSOCIATED WITH HUMAN TUMORS.
FI930580A (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
DK0403156T3 (da) Forbedrede monoklonale antistoffer mod den humane alfa/beta-T-cellereceptor samt fremstilling og anvendelse deraf
IE832452L (en) Lymphocyte growth factor
AU612683B2 (en) Synthetic peptides, antibodies directed against them, and the use thereof
ATE151882T1 (de) Karzinomverwandtes haptoglobin (hpr)
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
DE3884646D1 (de) Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper.
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
ATE72400T1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
IT8026986A0 (it) Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
GB2233091A (en) Immunoassays using monoclonal antibodies directed against natural binding proteins
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
DK329789D0 (da) Monoklonalt antistof
ATE86261T1 (de) Tumorassoziiertes antigen.
DE69111429D1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
ATE92081T1 (de) Tumorassoziiertes antigen.
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
GR890100333A (en) Antihuman antigen antibodies

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8601644-1

Effective date: 19911108

Format of ref document f/p: F